Pancreatic a cells proliferate at a low rate, and little is known about the control of this process. Here we report the characterization of human a cells by large-scale, single-cell RNA sequencing coupled with pseudotime ordering. We identified two large subpopulations and a smaller cluster of proliferating a cells with increased expression of genes involved in cell-cycle regulation. The proliferating a cells were differentiated, had normal levels of GCG expression, and showed no signs of cellular stress. Proliferating a cells were detected in both the G1S and G2M phases of the cell cycle. Human a cells proliferate at a fivefold higher rate than human b cells and express lower levels of the cell-cycle inhibitors CDKN1A and CDKN1C. Collectively, this study provides the gene signatures of human a cells and the genes involved in their cell division. The lower expression of two cell-cycle inhibitors in human a cells could account for their higher rate of proliferation compared with their insulin-producing counterparts. (Endocrinology 159: 3177-3186, 2018) 
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Pancreatic a cells proliferate at a low rate, and little is known about the control of this process. Here we report the characterization of human a cells by large-scale, single-cell RNA sequencing coupled with pseudotime ordering. We identified two large subpopulations and a smaller cluster of proliferating a cells with increased expression of genes involved in cell-cycle regulation. The proliferating a cells were differentiated, had normal levels of GCG expression, and showed no signs of cellular stress. Proliferating a cells were detected in both the G1S and G2M phases of the cell cycle. Human a cells proliferate at a fivefold higher rate than human b cells and express lower levels of the cell-cycle inhibitors CDKN1A and CDKN1C. Collectively, this study provides the gene signatures of human a cells and the genes involved in their cell division. The lower expression of two cell-cycle inhibitors in human a cells could account for their higher rate of proliferation compared with their insulin-producing counterparts. (Endocrinology 159: [3177] [3178] [3179] [3180] [3181] [3182] [3183] [3184] [3185] [3186] 2018) T he initiation and progression of the cell cycle requires a tightly regulated transcriptional program and results in cell division. Cyclins and cyclin-dependent kinases (CDKs) form heterodimer complexes and are key regulators of this transcriptional network. Their activation and subsequent inactivation help drive the different phases of the cell cycle (1) . Transcription factors also play a key role in the regulation of the cell-cycle machinery (1) .
It is well established that the early postnatal stages in mice (days or weeks) and humans (a few years) are associated with expansion of the endocrine islet mass (2, 3) . After this initial expansion, the proliferation rate decreases to very low levels (4) . Although it has been a focus to understand the mechanisms governing the a-cell expansion during development, insights into the factors and pathways orchestrating the proliferation of adult a cells have only started to emerge. A recent study using transcriptomics analysis of islet cells from fetal and adult mice was able to capture cells undergoing proliferation (5) . Not surprisingly, the majority of the proliferating cells pertained to the embryonic and juvenile stages and a higher ratio of proliferating a cells compared with b cells was observed. Although these findings shed light on the genes regulating division of a and b cells in mice, comparable knowledge in humans is limited to detection of few proliferating a cells with distinct gene signatures (6, 7) .
In the current study, we obtained the transcriptomes of .6000 a cells by RNA sequencing (RNA-seq) of single islet cells isolated from 12 donors without diabetes. The cells divided into three subpopulations, two large and homogeneous subpopulations and a distinct cluster of proliferating a cells. We used pseudotime analysis to investigate the progression of gene expression changes in the proliferating a cells. This was obtained by projecting each cell onto a trajectory. The ordered sequence of the cells provides a higher resolution view of the genes important for the control of the various stages of the cell cycle. We also interrogated how these genes provide a cells with greater proliferation capacity than their insulin-producing counterparts obtained during the same sequencing effort.
Material and Methods

Human islet processing
Human cadaveric islets were procured from Prodo Laboratories. Information regarding the 12 donors without diabetes analyzed in this study, along with their diabetes status and, when available, their hemoglobin A1c is provided in Supplemental Table 1 . We received the islets 4 to 6 days after the isolation. Islets were plated in complete Prodo Islet Media [PIM (S)] supplemented with glutamine/glutathione [PIM(G)] and human AB serum [PIM(ABS)] and incubated overnight in a tissue culture incubator at 37°C with a 5% CO 2 in air atmosphere before dissociating into single cells. Handpicked islets were enzymatically digested at 37°C for 10 minutes using TrypLE Express (Life Technologies). Subsequently, the cells were filtered in a 30-mm strainer and centrifuged. Afterward, cells were resuspended in 1X PBS containing 0.04% BSA. This process was immediately followed by loading and sequencing of the cells. Viability of the cells was measured using Trypan blue staining (91.2 6 3.3% cell viability; n = 12).
RNA fluorescence in situ hybridization of dissociated islet cells
Cytospin was used to place dissociated islet cells on microscope slides. The cells were fixed in 10% neutral formalin for 35 minutes. Dissociated cells underwent a process of permeabilization followed by hybridization with mRNA probes for GCG and CDK1, MKI67, RRM2, and TOP2A. The hybridization process was performed per the manufacturer's instructions (Advanced Cell Diagnostics). Fluorescein and Cy3 fluorescent signals were amplified using a fluorescent kit. Images were captured using a microscope slide scanner (Zeiss Axio Scan.Z1). To quantify the fluorescence intensity signal, the RNA fluorescence in situ hybridization (FISH) analysis module from HALO image software (Indica Laboratories) was used.
Single-cell RNA-seq and read mapping Single cells suspended in PBS with 0.04% BSA were loaded on a Chromium Single Cell Instrument (10X Genomics). RNAseq libraries were prepared using Chromium Single Cell 3 0 Library, Gel Beads, and Multiplex Kit (10X Genomics). Pairedend sequencing was performed on Illumina NextSeq500 with Read 1 for a 59-bp transcript read, Read 2 for 14-bp I7 index for cell barcode, 8-bp I5 index for sample index, and 10-bp unique molecular identifier (UMI). The Cell Ranger Single-Cell Software Suite (10X Genomics; v1.1.0) was used to perform sample demultiplexing, alignment, filtering, and UMI counting. The Human B37.3 Genome assembly and University of California, Santa Cruz, gene model were used for the alignment.
Single-cell data analysis
As part of the quality control process, cells were removed if the number of detected genes was ,500, total number of UMI was ,3000, or viability score was .0.2 (8) . Viability score was defined by the ratio of the sum of UMI for MT-RNR2, MT-ND1, MT-CO1, MT-CO2, MT-ATP8, MT-ATP6, MT-CO3, and MT-CYB expression to total UMI. Low viability was indicated by a higher score. To identify islet endocrine cell types, densityMclust (mclust package in R) was used to define two expression groups (high and low) of GCG, INS, SST, and PPY. Cells with more than one hormone in the high-expression group were excluded. Single-hormone cells were identified as a (GCGhigh only), b (INS-high only), d (SST-high only), PP (PPY-high only), and « (GHRL-high only) cells.
Clustering of retained endocrine and nonendocrine cells was identified by Seurat (R package; Satija Lab) using 1166 variable genes. Enriched genes among the a-cell subpopulations were found by FindMarkers in Seurat with a P value ,0.05 and logscale fold change .0.25. Enriched endocrine genes were obtained by comparing endocrine cells (a, b, d, PP, and « cells) with the nonendocrine cells.
Pseudotime trajectory reconstruction
Monocle (R package) was used to reconstruct pseudotime ordering of a cells with the default setting. The input genes for pseudotime ordering were a-cell subpopulation enriched genes. Cells from all 12 donors exhibited relatively uniform distribution along the trajectory and were used for the pseudotime analysis (Supplemental Fig. 1B ). The pseudotime trajectory had two states: Proliferating state and Other state. Branch-dependent significant genes were identified by BEAM function in monocle and with a q value ,0.01. Differentially expressed genes along the Proliferating branch were identified by removing cells in the Other state, and significant genes were those with a q value ,1e 210 .
Pathway enrichment
Enriched a-cell genes and branch-dependent genes were analyzed for pathway enrichment with GO, Kyoto Encyclopedia of Genes and Genomes (KEGG), and Reactome by clusterProfiler (R package). Top enriched pathways were selected based on P value.
Biological process score calculation
A composite score for each cell was calculated by the mean of gene expression (scaled UMI) in a predefined pathway or biological process. Three biological processes were used in the study: unfolded protein response (UPR), apoptosis, and cell cycle. The gene sets were obtained from IPA Ingenuity, KEGG, and Dominguez et al. (9) (Supplemental Table 2 ). To estimate empirical P value of a composite score, the score distribution was generated by composite scores of randomly selected genes for each cell with 1000 iterations. Proliferating a and b cells were identified using cell-cycle scores with and empirical P , 0.001 (accession no. GSE114297).
Results
Human a cells contain a subpopulation of highly proliferative cells
Unbiased clustering of human islet cells revealed three subpopulations of a cells; two large and homogenous subpopulations with 26 and 6 uniquely enriched genes and a smaller and more distinct subpopulation with 974 uniquely enriched genes ( Fig. 1A ; Supplemental Table 3 ). Pathway analysis of the third subpopulation revealed enrichment of genes associated with cell cycle and division (Fig. 1B) . To explore the differentiation state of these subpopulations, and more specifically if the proliferative subgroup possesses progenitor features, we calculated a score for each cell that reflects the expression of endocrine marker genes. Figure 1C shows no difference in the endocrine score between the three a-cell subpopulations. Furthermore, the three a-cell subpopulations clustered together, but separated from nonendocrine cells in hierarchical clustering based on the expression of the highly abundant endocrine genes, demonstrating that both subpopulations represent fully differentiated a cells (Fig. 1D) . Thus, human a cells comprise three subpopulations of fully differentiated cells with a smaller and distinctive proliferative subgroup among them.
RNA-FISH confirms the existence of the a-cell proliferative subpopulation
To validate the existence of proliferating a cells, we performed RNA-FISH simultaneous to GCG and CDK1, MKI67, RRM2, and TOP2A using freshly isolated human islets. These genes are significantly enriched in the proliferating a cells and important for cell-cycle regulation (1, 9, 10). We identified a cells coexpressing these proliferation markers, which were often undergoing mitosis ( Fig. 2A) . Quantification of the marker genes showed consistency in the fraction of cells with increased expression between the RNA-seq and RNA-FISH analyses (Fig. 2B ).
Pseudotime analysis reveals proliferation trajectory
To characterize the functional and temporal relationship between the a-cell subpopulations, we performed pseudotime analysis using their enriched marker genes (Supplemental Fig. 1A ). The majority of the cells had similar transcriptome profiles and was found in the root (Root state). We detected one branch decision point leading to two states of relatively minor cell numbers ( Fig. 3A) . One of the states contained cells with high enrichment of genes associated with cell proliferation (Proliferating state). The Other state was associated with 52 differentially expressed genes that did not translate into important enrichment of any biological pathways ( Fig. 3B ; Supplemental Table 4 ). Interestingly, the Proliferating state was longer in comparison with the Other state in pseudotime. In fact, although the Root state and Other state measured up to 12 in pseudotime, the Proliferating state occupied from 12 to 23 in pseudotime (Supplemental Fig. 1A ). We hypothesized that the long pseudotime of the Proliferating state might reflect different phases in the cell cycle. Using a cell-cycle score, we found this to be the case because there was a progressive increase in cell-cycle score along the Proliferating state (Fig. 3C) . Consistent with this, a cells in the beginning of the Proliferating state showed higher G1S proliferation score, whereas cells at the middle-end of the Proliferating state showed higher G2M score ( Fig. 3D; Supplemental  Fig. 2 ). Proliferating state was composed of 123 cells. The original 33 proliferating a cells in the "a-cell sub3 group" were located in the middle-end of the Proliferating state, indicating that "a-cell sub3 group" was primarily composed of cells in the G2M phase and with a strong proliferative gene signature (Supplemental Fig. 1C) . Overall, pseudotime analysis allowed us to observe a trajectory of proliferation in human a cells in the different phases of cell division. Cell-cycle regulators of human a-cell proliferation To investigate the genes important in regulating a-cell proliferation, we focused on the pseudotime trajectory containing the Root state and Proliferating state branches. We found 942 genes to be differentially expressed along this trajectory with a q value ,1e
210 (Supplemental Table 5 ). As expected, pathway analysis revealed enrichment of cell-cycle genes (Supplemental Table 6 ). From this category (KEGG hsa04110), we explored the expression of the 22 significantly regulated cell-cycle genes and plotted their expression in all cells along the pseudotime (Fig. 4 ; Supplemental Fig. 3 ). Interestingly, we found three classes of cyclins to be significantly expressed along the pseudotime: CCNE2, a cyclin important during the G1/S phase; CCNA2, which plays a key role during the S phase; and CCNB1-CCNB2, which regulates events during the G2M transition and progression through mitosis (1) . Of interest, these cyclin genes exhibited different temporal expression profile along the pseudotime consistent with their function at different phases of the cell cycle (Fig. 4) . As mentioned previously, cyclins heterodimerize with CDKs, which serve as the catalytic subunits (1). Consistent with this, we found CDK1 to be enriched at the Proliferating state with a progressive increase in expression toward the middle-end of the trajectory (Fig. 4) . Interestingly, previous research has shown that CDK1 can by itself complete progression of the mammalian cell cycle (11) . Among other cell-cycle regulators, we found differential expression of cell-cycle inhibitors. Among the CDK interacting protein/kinase inhibitory protein family, CDKN1A showed a modest increase at the beginning of the Proliferating state and was then mostly depleted for the remainder of the state (Supplemental Fig. 3 ). Members of this family of inhibitors have broad effects on cellcycle progression (1). Consistent with this, their low expression during most of the Proliferating state might be essential for the cell cycle to progress successfully. We also found members of the CDK4 inhibitor family to be differentially expressed: CDKN2A, CDKN2C, and CDKN2D presented with different patterns of expression as well (Supplemental Fig. 3 ). Overall, we uncovered genes important for a-cell division. Their enrichment and expression patterns within the Proliferating state trajectory provide valuable information for the understanding of human a-cell proliferation.
Transcriptional regulators of human a-cell proliferation
To understand the regulation of cell-cycle initiation and progression in human a cells, we next focused on the 42 transcription factors and regulators that were differentially expressed along the pseudotime trajectory ( Fig. 5; Supplemental Fig. 4 ; Supplemental Table 5 ). Although some of them have not been well characterized, others have known functions in the cell-cycle process. Figure 5 shows TFDP1 to be enriched in the beginning of the Proliferating state. TFDP1 dimerizes with the E2F1 transcription factor and regulates expression of genes important during the G1/S phase transition (12) . Interestingly, we found that E2F1 was significantly enriched in the Proliferating state (q value ,9e 29 ). Because we used a stringent cutoff, it was not included in the present list. We also found FOXM1 to be enriched in proliferating a cells. Overexpression of FOXM1 in human islets induces the expression of cell-cycle regulators (A-type, B-type, and E-type cyclins), chromosome complex passenger genes (BIRC5, AURKB, PLK1, and CDCA8), and anaphase-promoting complex system factor (CDC20), among others (13) . The majority of these FOXM1 target genes are significantly enriched in the a-cell Proliferating state (Supplemental Table 5 ). Although overexpression of FOXM1 in human islets induced proliferation and activation of many cell-cycle genes, the expression of D-type cyclins was not affected (13) . This is consistent with the lack of expression changes of the D-type cyclins in the current study.
We observed HES1 expression to be increased in the Proliferating state (Fig. 5) . HES1 regulates proliferation of neural stem cells by blocking differentiation and the cell-cycle inhibitor p21 CIP1/WAF1 (14) . During pancreas development, Hes1, through its regulation of p57 Kip2 ,
coordinates the balance between proliferation and cellcycle exit and thereby the number of progenitor cells (15) . We also found that the inhibitor of differentiation proteins ID1 and ID3 were enriched in the beginning of the Proliferating state (Fig. 5) . They are upregulated in several types of tumors and form heterodimers with bHLH proteins to inhibit their DNA-binding activity (16) . Of interest, in neural stem cells, these transcription factors release the negative auto loop regulation of Hes1 (17). Last, the novel transcription factor TCF19 has been found to be important for proliferation and survival in the INS-1 b-cell line (18) . In addition to transcription factors, we investigated whether epigenetic processes could influence a cell-cycle regulation. We curated the database EpiFactors (19) and found 38 of the genes to be differentially expressed along the pseudotime trajectory ( Fig. 6; Supplemental Fig. 5 ; Supplemental Table 5 ). Among them were factors with functions related to modification of histone methylation (EZH2), acetylation (ELP5, MORF4L2, NCOR1, PHF19, SUDS3, DNAJC1), deacetylation (DNAJC1), ubiquitination (UBE2B, UBE2D1, UBE2T), and phosphorylation (AURKA, AURKB, CDK1, PBK, PPP2CA, PPP4C). Interestingly, the PRC2 complex components EZH2, RBBP7, and PHF19 showed significantly enriched expression in the Proliferating state trajectory (Fig. 6) . EZH2 is the catalytic component of the PRC2 complex. It is regulated by the E2F/pRB pathway and functions as a methyl transferase for lysine 9 (H3K9) and lysine 27 (H3K27) (20) . In human breast cancer cells, EZH2 is a key contributor to the suppression of CDKN1C through its trimethylation of histone H3 lys 27 (21) . In human insulinomas, EZH2 possesses a gain of copy number variation, and its overexpression in combination with CDKN1C silencing was more efficient at inducing b-cell proliferation than modulation of expression of each factor alone (22) . In human b cells, the levels of EZH2 mRNA and protein decrease with age (23). Thus, it is possible that epigenetic regulation by the PRC2 complex contributes to regulation of human a-cell proliferation.
Overall, pseudotime analysis revealed 42 transcription factors or regulators and 38 epigenetic regulators with differential expression in human proliferating a cells. Although some of the factors are important for the control of the cell cycle in other cell types, little is known about their function in human a-cell proliferation. Hormone expression and cellular stress do not promote human a-cell proliferation We next sought to understand a potential trigger for human a-cell proliferation. In mouse b cells, it has been reported that cellular stress and low expression of insulin promote cell proliferation (24, 25) . We calculated a composite score representing the mRNA abundance of the genes involved in the UPR and found that the proliferative a cells are lower in UPR score compared with the cells in Root state (Fig. 7A) . Apoptosis score was also low throughout the a-cell population, indicating the scarcity of apoptosing a cells captured in our analysis (Fig. 7B) . GCG expression did not correlate with a-cell proliferation (Supplemental Figure 6) . Taken together, these data suggest that the signal triggering a-cell proliferation is distinct from those for b cells.
CDKN1A and CDKN1C expression and human a-and b-cell proliferation During our sequencing effort, we also identified 6241 b cells (26) . Consistent with previous findings (4, 6), we detected more proliferating a cells (0.94%; n = 6465) than b cells (0.16%; n = 6241). These observations correlated well with the lower cell-cycle composite scores of proliferating b cells than those of a cells (Fig. 8A) . Then why are a cells more likely to proliferate than b cells? We hypothesized that cellcycle inhibitors might be more highly expressed in b cells, inhibiting cell-cycle entry. Indeed, we found that cell-cycle inhibitors CDKN1A and CDKN1C were significantly higher in b cells than in a cells at the nonproliferating state (Fig. 8B) . CDKN1C encodes the cyclin-dependent kinase inhibitor P57 KIP2 , which inhibits the activity of several cyclin/CDK complexes (1). Importantly, their repression in human islets increased b-cell proliferation (22, 27, 28) . Furthermore, loss of CDKN1C expression is detected in focal lesions of congenital hyperinsulinism, in pediatric and adult insulinomas, and in Beckwith-Wiedemann syndrome, which is associated with hypoglycemia (22, (29) (30) (31) (32) . Thus, the lower expression of these cell-cycle inhibitors in a cells could contribute to their higher proliferation rate.
Discussion
RNA-seq of .6000 single human a cells and pseudotime reconstruction of their transcriptomes revealed a trajectory composed of proliferating cells. We detected a cells in the G1/S and G2/M phases of the cell cycle and uncovered temporal changes in expression of genes associated with cell-cycle progression, as well as novel transcription factors and epigenetic regulatory components. As part of the analysis, we included proliferating b cells identified in the same sequencing effort. We found that a cells proliferate at a fivefold higher rate than b cells, even when originating from the same donors. This is consistent with long-term labeling studies in mice and recent single human islet cell studies demonstrating very slow turnover of b cells in the adult stage (4, 5, 33) . It is tempting to speculate that the higher expression of the cell-cycle inhibitors CDKN1A and CDKN1C in b cells could explain the lower rate of cell division. The proliferating b cells were high in G1S score, but had an overall low expression of cell cycle-related genes. Human a-cell mass remains relatively constant over time and is little affected by diabetes development (4, 34, 35) . This would suggest equal rates of a-cell proliferation and death. It was therefore surprising that the apoptosis score was low in a cells and that a distinct a-cell subpopulation with a high score did not emerge in our pseudotime analysis. Additional work is therefore required to identify the mechanism(s) regulating a-cell death. Adult human a cells remain fully differentiated while undergoing proliferation and no progenitor markers were detected. We were not able to detect the recently described a-related cell population characterized by the expression of the a-cell marker ARX, the progenitor marker SOX9, and having little to no expression of GCG (36). This is not surprising because the a-related cell population was abundant in children and adolescent and our study was conducted on islet cells from adult donors. Collectively, these data suggest that the main source of new a cells might change with age from a progenitorlike population in early life to replication of existing a cells in adulthood.
Apart from the highly proliferative subpopulation, the transcriptomes of the a cells were fairly homogenous and no distinct functional states were detected in the pseudotime trajectory. Along these lines, we found no indication of stress or UPR activation. This could be explained by the observations that glucagon is less likely to misfold than insulin and that a cells are more resistant to metabolic stress than b cells (34) . The lower propensity to develop cellular and metabolic stress might explain why a-cell mass, but not the b-cell mass, remains unchanged in type 2 diabetes (35, 37, 38) .
In conclusion, we unveiled key genes important for control of human a-cell proliferation. We show how the expression of these genes changes in a coordinated manner during cell division. For some of these genes, little is known about their function in the cell cycle, offering an opportunity for further exploration. Understanding the gene signatures of a cells and the mechanisms of proliferation could be of importance in ongoing research efforts to try to replenish the b-cell pool in type 2 diabetes via reprogramming of a cells.
